MedWatch

This year's most read stories from MedWatch

MedWatch has kept you updated in our daily newsletter throughout the year. Here's the list over the top stories from 2021.

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Latest news

See all jobs